Tenax Therapeutics (TENX) USPTO patents

Utility

LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (PH-HFpEF)

6 Apr 23

This invention relates to the treatment of Pulmonary Hypertension with heart failure with preserved ejection fraction (PH-HFpEF).

Stuart Rich, Douglas Randall, Douglas Hay

Filed: 18 Nov 22

Utility

Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)

21 Mar 23

This invention relates to the treatment of Pulmonary Hypertension with heart failure with preserved ejection fraction (PH-HFpEF).

Stuart Rich, Douglas Randall, Douglas Hay

Filed: 24 Aug 21

Utility

Pharmaceutical Compositions for Subcutaneous Administration of Levosimendan

31 Mar 22

A composition containing levosimendan, one or more solubilizing and/or stabilizing agents, and one or more additional pharmaceutically acceptable additives.

Doug Randall, Douglas Hay, Nancy J. M. Hecox

Filed: 8 Dec 21

Utility

Pharmaceutical compositions for subcutaneous administration of levosimendan

4 Jan 22

A composition containing levosimendan, one or more solubilizing and/or stabilizing agents, and one or more additional pharmaceutically acceptable additives.

Doug Randall, Douglas Hay, Nancy J. M. Hecox

Filed: 19 Aug 19

Utility

LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (PH-HFpEF)

23 Dec 21

This invention relates to the treatment of Pulmonary Hypertension with heart failure with preserved ejection fraction (PH-HFpEF).

Douglas Randall, Douglas Hay

Filed: 24 Aug 21

Utility

LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (PH-HFpEF)

17 Jun 21

This invention relates to the treatment of Pulmonary Hypertension with heart failure with preserved ejection fraction (PH-HFpEF).

Douglas Randall, Douglas Hay

Filed: 15 Dec 20

Utility

Pharmaceutical Compositions for Subcutaneous Administration of Levosimendan

21 Oct 20

A composition containing levosimendan, one or more solubilizing and/or stabilizing agents, and one or more additional pharmaceutically acceptable additives.

Doug Randall, Douglas Hay, Nancy J.M. Hecox

Filed: 18 Aug 19

Utility

Containing element, structure of reinforced ground, process of making said structure of reinforced ground

28 Sep 20

A containing element to be used in geotechnical applications, including: a facing body made of a cementitious material having an inner face configured for contacting the ground and an outer face opposite to the inner face with respect to the body itself, a monolithic reticular structure made of plastic material having a plurality of first and second elements intersecting each other at respective nodes in order to form meshes.

Cesare Beretta, Luca Mottadelli

Filed: 8 Feb 16